Palvella Therapeutics, Inc. (PVLA)
116.11
+0.61
(+0.53%)
USD |
NASDAQ |
May 21, 16:00
116.11
0.00 (0.00%)
After-Hours: 19:59
Palvella Therapeutics EPS Diluted (Quarterly) : -1.205 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 1.467 |
| Novavax, Inc. | -0.0581 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Vanda Pharmaceuticals, Inc. | -0.8168 |
| SELLAS Life Sciences Group, Inc. | -0.0487 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.77M |
| Total Expenses (Quarterly) | 15.77M |
| Enterprise Value | 1.395B |
| Earnings Yield | -3.59% |
| Normalized Earnings Yield | -3.561 |